Chamber Hill Strategies Recognized as a Top-Performer
- May 18, 2021
Bloomberg Government recognizes Chamber Hill Strategies as a top-performing lobbying firm out of 2,139 registered lobbying firms in 2019.
Bell Provides Insight into the New Congress, Administration
- May 11, 2021
Jennifer Bell, founding partner, provided political context for and strategic insights into “The Biden Administration, the 117 Congress, and What We Might See in Healthcare” at the Society of Hospital Medicine Annual Meeting.
Bell: What to Expect in 2021
- April 16, 2021
Check out the latest video interview from the National Association of Elder Law Attorneys’ Federal Advocacy Committee co-chairs with Jennifer Bell of Chamber Hill Strategies and NAELA’s Director of Advocacy, David M. Goldfarb, on what members can expect inside the beltway in 2021; how NAELA navigated advocacy during the COVID-19 crisis; and more!
Bell Discusses Healthcare Equity
- April 14, 2021
In the final episode of A&M Healthcare Industry Group’s podcast series on the impact of the new Administration, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, and Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, discussed the Biden Administration’s commitment to “equity” in healthcare. The experts also weigh in to provide some perspectives on who is on the “in” and who is on the “out” in this Administration.
Bell Talks Rx Pricing Reform
- April 7, 2021
In part two of A&M Healthcare Industry Group’s podcast series, Jennifer Bell, Founding Partner of Chamber Hill Strategies and Dr. David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs, continued their discussion with Peter Urbanowicz, A&M’s Healthcare Industry Group Co-Head, on the Biden Administration’s impact on healthcare policy by focusing on President Biden’s campaign promises for healthcare and how and when they may come to fruition.
Bell Discusses Drug Pricing and 340B Outlook for 2021
- February 11, 2021
Jennifer Bell, founding partner, previewed what 2021 looks like for drug pricing, 340B, and oncology care at the annual meeting of the Association of Cancer Executives.
Chamber Hill Strategies Recognized as a Top-Performer
- April 7, 2020
Bloomberg Government recognizes Chamber Hill Strategies as a top-performing lobbying firm out of 2,095 registered lobbying firms in 2020.